TPN had been described to increase intratumoral uptake through binding to integrins by tumor penetrating iRGD followed by proteolytic cleavage and initiation of transcytosis through a semaphorin receptor NRP1 which is highly expressed on tumor cells. This evidence concerns the gene NRP1 and neoplasm.